Reactivation of Multidrug-Resistant HSV-1 in a Post-Allogenic Hematopoietic Stem Cell Transplant Patient: Dynamic Detection of the Rare A605V Mutation by Next-Generation Sequencing

Publication date

2024-05-01

Authors

Zheng, Shuxuan
Rümke, Lidewij
Tello Rubio, Bruno
Rogers, Malbert
Van Sluis, Geerte L
Kuball, JurgenORCID 0000-0002-3914-7806
Riezebos-Brilman, A.ISNI 0000000395683838
Lebbink, Robert JanORCID 0000-0002-1981-0420ISNI 0000000393301103
Verduyn Lunell, FISNI 0000000392973493

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

We present an immunocompromised patient with a multiresistant herpes simplex virus-1 reactivation with a rare mutation (A605V) in the viral DNA polymerase gene. Next-generation sequencing suggests the presence of multiple drug-resistant strains before treatment and altered ratios during treatment, affecting the clinical response to aciclovir and foscarnet.

Keywords

aciclovir, foscarnet, HSV-1, multidrug resistance, stem cell transplantation, Oncology, Infectious Diseases

Citation

Zheng, S, Rümke, L L W, Tello Rubio, B, Rogers, M R C, Van Sluis, G L, Kuball, J H E, Riezebos-Brilman, A, Lebbink, R J & Verduyn Lunel, F M 2024, 'Reactivation of Multidrug-Resistant HSV-1 in a Post-Allogenic Hematopoietic Stem Cell Transplant Patient : Dynamic Detection of the Rare A605V Mutation by Next-Generation Sequencing', Open Forum Infectious Diseases, vol. 11, no. 5, ofae250. https://doi.org/10.1093/ofid/ofae250